[go: up one dir, main page]

IT201900023016A1 - Formulations comprising a mineral and a polysaccharide, their compositions and their use in the supplementation of said mineral - Google Patents

Formulations comprising a mineral and a polysaccharide, their compositions and their use in the supplementation of said mineral

Info

Publication number
IT201900023016A1
IT201900023016A1 IT102019000023016A IT201900023016A IT201900023016A1 IT 201900023016 A1 IT201900023016 A1 IT 201900023016A1 IT 102019000023016 A IT102019000023016 A IT 102019000023016A IT 201900023016 A IT201900023016 A IT 201900023016A IT 201900023016 A1 IT201900023016 A1 IT 201900023016A1
Authority
IT
Italy
Prior art keywords
mineral
supplementation
polysaccharide
formulations
compositions
Prior art date
Application number
IT102019000023016A
Other languages
Italian (it)
Inventor
Andrea Lacorte
Germano Tarantino
Elisa Brilli
Original Assignee
Alesco Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alesco Srl filed Critical Alesco Srl
Priority to IT102019000023016A priority Critical patent/IT201900023016A1/en
Priority to PCT/IB2020/061521 priority patent/WO2021111404A1/en
Priority to CN202080095135.4A priority patent/CN115052582A/en
Priority to AU2020396464A priority patent/AU2020396464A1/en
Priority to CA3163312A priority patent/CA3163312A1/en
Priority to IL293452A priority patent/IL293452A/en
Priority to GEAP202515978A priority patent/GEP20257836B/en
Priority to UAA202202107A priority patent/UA129875C2/en
Priority to JOP/2022/0136A priority patent/JOP20220136A1/en
Priority to KR1020227022883A priority patent/KR20220122654A/en
Priority to MX2022006828A priority patent/MX2022006828A/en
Priority to BR112022010834A priority patent/BR112022010834A2/en
Priority to US17/782,140 priority patent/US20230019690A1/en
Priority to JP2022533497A priority patent/JP2023505246A/en
Priority to EP20829656.6A priority patent/EP4069194A1/en
Publication of IT201900023016A1 publication Critical patent/IT201900023016A1/en
Priority to SA522432861A priority patent/SA522432861B1/en
Priority to ECSENADI202247989A priority patent/ECSP22047989A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
IT102019000023016A 2019-12-04 2019-12-04 Formulations comprising a mineral and a polysaccharide, their compositions and their use in the supplementation of said mineral IT201900023016A1 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT102019000023016A IT201900023016A1 (en) 2019-12-04 2019-12-04 Formulations comprising a mineral and a polysaccharide, their compositions and their use in the supplementation of said mineral
UAA202202107A UA129875C2 (en) 2019-12-04 2020-12-04 PREPARATIONS CONTAINING A MINERAL AND/OR VITAMIN AND A POLYSACCHARIDE, THEIR COMPOSITIONS AND THEIR USE FOR SUPPLEMENTATION WITH SAID MINERAL AND/OR VITAMIN
MX2022006828A MX2022006828A (en) 2019-12-04 2020-12-04 Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin.
AU2020396464A AU2020396464A1 (en) 2019-12-04 2020-12-04 Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin
CA3163312A CA3163312A1 (en) 2019-12-04 2020-12-04 Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin
IL293452A IL293452A (en) 2019-12-04 2020-12-04 Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin
GEAP202515978A GEP20257836B (en) 2019-12-04 2020-12-04 Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin
PCT/IB2020/061521 WO2021111404A1 (en) 2019-12-04 2020-12-04 Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin
JOP/2022/0136A JOP20220136A1 (en) 2019-12-04 2020-12-04 Formulations comprising a mineral and/or vitamin and polysaccharide, combinations thereof and their use in said mineral and/or vitamin supplement
KR1020227022883A KR20220122654A (en) 2019-12-04 2020-12-04 Preparations comprising minerals and/or vitamins and polysaccharides, compositions thereof and their use in mineral and/or vitamin supplementation
CN202080095135.4A CN115052582A (en) 2019-12-04 2020-12-04 Preparation containing mineral and/or vitamin and polysaccharide, its composition and its application in supplementing mineral and/or vitamin
BR112022010834A BR112022010834A2 (en) 2019-12-04 2020-12-04 FORMULATIONS INCLUDING A MINERAL AND/OR A VITAMIN AND A POLYSACCHARIDE, COMPOSITIONS THEREOF AND USE THEREOF IN SUPPLEMENTATION OF SUCH MINERAL AND/OR VITAMIN
US17/782,140 US20230019690A1 (en) 2019-12-04 2020-12-04 Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin
JP2022533497A JP2023505246A (en) 2019-12-04 2020-12-04 Preparations containing minerals and/or vitamins and polysaccharides, compositions thereof and their use in supplementation of said minerals and/or vitamins
EP20829656.6A EP4069194A1 (en) 2019-12-04 2020-12-04 Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin
SA522432861A SA522432861B1 (en) 2019-12-04 2022-06-02 Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin
ECSENADI202247989A ECSP22047989A (en) 2019-12-04 2022-06-15 Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in the supplementation of said mineral and/or vitamin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000023016A IT201900023016A1 (en) 2019-12-04 2019-12-04 Formulations comprising a mineral and a polysaccharide, their compositions and their use in the supplementation of said mineral

Publications (1)

Publication Number Publication Date
IT201900023016A1 true IT201900023016A1 (en) 2021-06-04

Family

ID=70154909

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102019000023016A IT201900023016A1 (en) 2019-12-04 2019-12-04 Formulations comprising a mineral and a polysaccharide, their compositions and their use in the supplementation of said mineral

Country Status (17)

Country Link
US (1) US20230019690A1 (en)
EP (1) EP4069194A1 (en)
JP (1) JP2023505246A (en)
KR (1) KR20220122654A (en)
CN (1) CN115052582A (en)
AU (1) AU2020396464A1 (en)
BR (1) BR112022010834A2 (en)
CA (1) CA3163312A1 (en)
EC (1) ECSP22047989A (en)
GE (1) GEP20257836B (en)
IL (1) IL293452A (en)
IT (1) IT201900023016A1 (en)
JO (1) JOP20220136A1 (en)
MX (1) MX2022006828A (en)
SA (1) SA522432861B1 (en)
UA (1) UA129875C2 (en)
WO (1) WO2021111404A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202200010583A1 (en) * 2022-05-23 2023-11-23 Neilos S R L “Nutraceutical or pharmaceutical composition for male infertility”
WO2025056416A1 (en) * 2023-09-11 2025-03-20 Dsm Ip Assets B.V. Lipid matrix-based particles

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010021373A1 (en) * 1999-09-02 2001-09-13 Zyck Daniel J. Coated chewing gum products containing an acid blocker
CN101455401A (en) * 2009-01-16 2009-06-17 北京天维新探生物科技有限公司 Composite multi-functional food nutrient intensifying agent
CN102077944A (en) * 2010-09-20 2011-06-01 王强 Marine special dietary food special for prostate patient
WO2014009806A1 (en) 2012-07-31 2014-01-16 Alesco S.R.L. Solid composition comprising iron for use in iron deficient conditions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA86415B (en) * 1985-01-29 1986-09-24 Abbott Lab Enteral nutritional hypoallergenic formula
CN1077342A (en) * 1992-04-17 1993-10-20 金昌松 The compound method of rice, Noodles reinforced nutritious powder
US7744930B2 (en) * 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
WO2007094486A1 (en) * 2006-02-17 2007-08-23 Veritron Limited Accelerating agent of calcium absorption
CN101534796B (en) * 2006-10-31 2014-09-17 株式会社钟化 Granular composition containing physiologically active substance and its preparation method
JP2008174537A (en) * 2006-12-20 2008-07-31 Fujifilm Corp POWDER COMPOSITION AND FOOD COMPOSITION, COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
JP5733930B2 (en) * 2009-09-09 2015-06-10 武田薬品工業株式会社 Solid preparation
WO2012020279A1 (en) * 2010-08-13 2012-02-16 Compagnie Gervais Danone Product for the upper gastric sphere
KR101771774B1 (en) * 2014-03-21 2017-08-28 주식회사 엘지화학 Light curing resin composition for adhesive film and adhesive layer
JP7182872B2 (en) * 2014-10-29 2022-12-05 グリコム・アクティーゼルスカブ Synthetic compositions and methods for treatment of irritable bowel syndrome
US20160278415A1 (en) * 2015-01-30 2016-09-29 Nutrient Foods, Llc Food Compositions Containing All Essential Nutrients
WO2019013234A1 (en) * 2017-07-11 2019-01-17 武田コンシューマーヘルスケア株式会社 Solid preparation comprising vitamin b1 or derivative thereof
IT201800006288A1 (en) * 2018-06-13 2019-12-13 Compositions comprising sucrosomal minerals containing mineral salts for use in the conditions of deficiency of such minerals

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010021373A1 (en) * 1999-09-02 2001-09-13 Zyck Daniel J. Coated chewing gum products containing an acid blocker
CN101455401A (en) * 2009-01-16 2009-06-17 北京天维新探生物科技有限公司 Composite multi-functional food nutrient intensifying agent
CN102077944A (en) * 2010-09-20 2011-06-01 王强 Marine special dietary food special for prostate patient
WO2014009806A1 (en) 2012-07-31 2014-01-16 Alesco S.R.L. Solid composition comprising iron for use in iron deficient conditions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BECKER G ET AL: "Influence of fucoidan on the intestinal absorption of iron, cobalt, manganese and zinc in rats", DIGESTION, S. KARGER AG., BASEL, CH, vol. 21, no. 1, 1 January 1981 (1981-01-01), pages 6 - 12, XP009123143, ISSN: 0012-2823, DOI: 10.1159/000198512 *

Also Published As

Publication number Publication date
JP2023505246A (en) 2023-02-08
US20230019690A1 (en) 2023-01-19
WO2021111404A1 (en) 2021-06-10
KR20220122654A (en) 2022-09-02
JOP20220136A1 (en) 2023-01-30
SA522432861B1 (en) 2024-08-29
CA3163312A1 (en) 2021-06-10
ECSP22047989A (en) 2022-08-31
MX2022006828A (en) 2022-09-23
CN115052582A (en) 2022-09-13
GEP20257836B (en) 2025-12-10
UA129875C2 (en) 2025-08-27
AU2020396464A1 (en) 2022-06-16
GEAP202515978A (en) 2025-08-11
BR112022010834A2 (en) 2022-08-23
IL293452A (en) 2022-07-01
EP4069194A1 (en) 2022-10-12

Similar Documents

Publication Publication Date Title
PL3628691T3 (en) Amphiphilic polysaccharide derivatives and compositions comprising same
CO2019008103A2 (en) Pharmaceutical compositions for combination therapy
IT201600068623A1 (en) "USE OF A LIGNIN FRACTION AS AN ANTI-PHYTOPATHOGENIC AGENT AND ANTI-PHYTOPATHOGENIC COMPOSITIONS COMPRISING THE SAME" / "USE OF A FRACTION OF LIGNIN AS AN ANTIFYTOPATOGENIC AGENT AND ANTIFYTOPATOGENIC COMPOSITIONS THAT INCLUDE IT"
ZA201905763B (en) Liposomal compositions and solid oral dosage forms comprising the same
EP3897593A4 (en) Cannabinoid formulations and pharmaceutical compositions
BR112018006560A2 (en) oral hygiene compositions and methods of using the compositions.
IT201900023016A1 (en) Formulations comprising a mineral and a polysaccharide, their compositions and their use in the supplementation of said mineral
IT201700030541A1 (en) COMPOSITION AND KIT FOR USE IN THE PREVENTION OF RECIDIVATING OPTICOMYOSIS
EP3781165A4 (en) Aminopyrazines and related compounds useful as mitochondrial uncouplers
IL290516A (en) Compositions and their uses
IL290531A (en) Skin-care compositions and uses thereof
BR112018006204A2 (en) oral hygiene compositions and methods of using the compositions.
GB201901413D0 (en) Compositions and their use
HK40082157A (en) Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin
HK40063879A (en) Compositions comprising blautia hydrogenotrophica in the treatemnt of fibromyalgia
AU2019903734A0 (en) Inhalable compositions and uses thereof
PL3993777T3 (en) COMPRESSED MACITENTAN COMPOSITIONS, METHODS AND THEIR APPLICATIONS
HK40053323A (en) Immunogenic compositions and uses thereof
HK40051060A (en) Ivosidenib forms and pharmaceutical compositions
AU2019904921A0 (en) Compositions and uses thereof
AU2019904922A0 (en) Fatty acid compositions and the use thereof
EP4009790A4 (en) Neo-bavaisoflavone and compositions thereof and their use as pesticides
HK40068562A (en) Compositions and methods involving layilin
AU2018901814A0 (en) Aqueous cleaning compositions and the use thereof
AU2019903417A0 (en) Compositions and uses thereof